
YOUR LOGO HERE
SEMAX
10mg
For Research Use Only
Lot: —
Bulk Peptides Co.
Semax
10mg · 30mg
- Standard
- $210/kit
- 1,000+ vials
- $130/kit

YOUR LOGO HERE
SEMAX/SELANK BLEND
10mg/10mg
For Research Use Only
Lot: —
Bulk Peptides Co.
For Laboratory Research Use Only — Not for Human or Veterinary Use.
Minimum order: 100 vials total. Mix and match across all products.
| CAS Number | — |
|---|---|
| Molecular Formula | — |
| Molecular Weight | — |
| Purity | ≥98% (HPLC) |
| Form | Lyophilized Powder |
| Storage | -20°C, desiccated, protected from light |
| Reconstitution | Bacteriostatic water |
Every production lot is independently third-party tested. A batch-specific Certificate of Analysis — documenting HPLC purity, mass spectrometry identity confirmation, and net peptide content — is issued with every shipment. View a sample COA to see the format.
Two heptapeptides that share a design motif and nothing else. Their structural similarity is precisely what makes the blend difficult to analyse correctly.
This preparation combines two separately defined synthetic heptapeptides at a fixed ratio. Semax is Met-Glu-His-Phe-Pro-Gly-Pro, built on the ACTH(4-7) tetrapeptide core. Selank is Thr-Lys-Pro-Arg-Pro-Gly-Pro, built on the tuftsin tetrapeptide core. Being a mixture, it has no CAS number, no molecular formula and no molecular weight of its own.
The two share an unusual amount of design logic. Each is a short bioactive tetrapeptide extended at the C-terminus by the same Pro-Gly-Pro tripeptide, added for the same reason: to resist the exopeptidase activity that would otherwise clear a free tetrapeptide almost immediately. Both emerged from the same research tradition and the same structural strategy.
What they do not share is a target. The parent sequences are unrelated, one derived from a pituitary hormone fragment and the other from an immunoglobulin fragment, and the pathways described for each in the literature do not overlap. A shared stabilising extension is not a shared mechanism.
No primary literature examines this combination as a combination. The available evidence consists of two separate bodies of work on the individual peptides, and any expectation about the mixture is inference across them.
Reported work on Semax centres on neurotrophic gene and protein expression in rodent brain tissue and cultured neurons, including brain-derived neurotrophic factor and its receptor, along with melanocortin-linked signalling inherited from the ACTH-derived core. Reported work on Selank centres on enkephalin-degrading enzyme activity, GABA-A receptor subunit expression, monoamine turnover and cytokine transcript levels. Both literatures are concentrated in a small number of groups and substantially published in Russian-language journals.
The similarity between the two components is an analytical problem rather than a convenience. Both are heptapeptides, their masses differ by roughly sixty daltons, and they share the same C-terminal tripeptide, so their chromatographic behaviour is closer than that of most blend components. Co-elution or partial overlap is a real possibility with a generic gradient.
The shared Pro-Gly-Pro compounds this. Both peptides carry proline isomerism that broadens and splits peaks, so two partially overlapping broadened peaks can integrate into figures that do not represent the true ratio. Ultraviolet peak area alone is not a reliable basis for composition here, and the situation is worse because the two differ in chromophore content, Semax carrying histidine and phenylalanine while Selank carries no aromatic residue at all, so equal masses do not give equal absorbance.
The analysis that actually characterises this material is liquid chromatography with mass spectrometric detection, using extracted ion chromatograms for each component so that identity and quantity are established by mass rather than by retention time and absorbance. Column temperature should be controlled and stated for the same proline-related reason that applies to each peptide individually.
| Solubility | Both components are freely soluble in water. |
|---|---|
| Reconstitution | Dissolves readily. Swirl rather than shake. |
| Storage | Lyophilised solid at -20C, desiccated and protected from light. |
| Stability | The methionine at the N-terminus of the Semax component is the oxidation-sensitive site in the mixture and is the residue that limits its shelf behaviour, since the Selank component carries no comparable liability. Limit exposure to air and prefer aliquots over repeated access to one vial. |

YOUR LOGO HERE
SEMAX
10mg
For Research Use Only
Lot: —
Bulk Peptides Co.
10mg · 30mg

YOUR LOGO HERE
SELANK
10mg
For Research Use Only
Lot: —
Bulk Peptides Co.
10mg

YOUR LOGO HERE
DSIP
10mg
For Research Use Only
Lot: —
Bulk Peptides Co.
10mg

YOUR LOGO HERE
DIHEXA
10mg
For Research Use Only
Lot: —
Bulk Peptides Co.
10mg
For Laboratory Research Use Only — Not for Human or Veterinary Use